Free Trial
LON:N4P

N4 Pharma (N4P) Share Price, News & Analysis

N4 Pharma logo
GBX 0.35 -0.03 (-6.67%)
As of 07/3/2025 11:03 AM Eastern

About N4 Pharma Stock (LON:N4P)

Key Stats

Today's Range
0.35
0.40
50-Day Range
0.35
0.60
52-Week Range
0.35
0.80
Volume
1.78 million shs
Average Volume
2.19 million shs
Market Capitalization
£1.51 million
P/E Ratio
N/A
Dividend Yield
3.12%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive N4P Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for N4 Pharma and its competitors with MarketBeat's FREE daily newsletter.

N4P Stock News Headlines

N4 Pharma PLC reports change in major holdings
N4 Pharma PLC
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
N4 Pharma Plc Share Chat (N4P)
N4 Pharma PLC (N4P.AQ)
See More Headlines

N4P Stock Analysis - Frequently Asked Questions

N4 Pharma's stock was trading at GBX 0.54 at the start of the year. Since then, N4P shares have decreased by 34.6% and is now trading at GBX 0.35.

N4 Pharma Plc (LON:N4P) announced its quarterly earnings results on Monday, June, 9th. The company reported ($0.31) earnings per share (EPS) for the quarter. N4 Pharma had a negative net margin of 18,399.86% and a negative trailing twelve-month return on equity of 90.68%.

Shares of N4P stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that N4 Pharma investors own include 4D pharma (DDDD), Active Energy Group (AEG), B&M European Value Retail (BME), BP (BP), Coats Group (COA), EQTEC (EQT) and genedrive (GDR).

Company Calendar

Last Earnings
6/09/2025
Today
7/04/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
LON:N4P
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£1.63 million
Net Margins
-18,399.86%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£8.84 thousand
Cash Flow
GBX 0.16 per share
Price / Cash Flow
2.25
Book Value
GBX 0.45 per share
Price / Book
0.78

Miscellaneous

Free Float
N/A
Market Cap
£1.51 million
Optionable
Not Optionable
Beta
-0.37
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (LON:N4P) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners